Antibody-drug conjugates: A developing market with substantial growth potential
20:48 PM | January 20, 2014 | —Deepti Ramesh
The antibody-drug conjugates (ADCs) market, which is in its early stages of development, offers growth opportunities for several contract-manufacturing organizations (CMOs).
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.